
Alliance with Cerba HealthCare to advance metabolomics and drive diagnostic innovations
November 7, 2016
November 18, 2016.
[EVENTS] Company
Vincent Petit, CEO, and Romain Kaspereit, CFO of METAFORA Biosystems, were thrilled to participate to the 2016 Actionaria Event happening in Paris.
The event brought together over 25,600 investors at the Palais des Congrès. More than 120 listed and non-listed companies showcased their offerings, providing investors with the opportunity to connect with portfolio management experts and economics journalists to help them manage their investments effectively.
Vincent and Romain welcomed discussions at our booth and had the chance to meet with potential investors, fostering valuable connections that will support our growth.
Vincent also delivered three pitches during the crowdfunding sessions, which were met with numerous insightful questions about our diagnostics offerings. The engagement from the audience underscored the interest in our mission and innovations.
During his presentation, Vincent outlined the strategic plans of METAFORA Biosystems, emphasizing the company’s commitment to advancing diagnostic solutions for rare diseases. He highlighted the innovative approaches the company is taking to develop cutting-edge technologies that can significantly improve patient outcomes.
We are grateful for the community that has rallied around us during this event.
Watch the video of our Vincent pitching at the Actionaria Event and delivering insights on our company’s strategy and the innovaitve products we are developing:
About the event organizer
The Actionaria Event is a privileged meeting place for individual shareholders, SMEs, and listed companies, the 21st edition of the Actionaria fair, which took place on November 22nd and 23rd, confirmed its status as the largest European event dedicated to individual investors. It has established itself as the benchmark fair for connecting savers and businesses.
As METAFORA Biosystems continues its journey in the biotech landscape, the insights shared by Vincent and Romain at this meeting reflect the company’s dedication to innovation and its vision for a healthier future. The collaboration with international stakeholder and investors could be a game-changer in the quest to address unmet medical needs and improve the lives of patients worldwide.